0.05Open0.05Pre Close0 Volume148 Open Interest3.00Strike Price0.00Turnover561.53%IV660.60%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier24DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.2544Delta0.5514Gamma8.03Leverage Ratio-0.0038Theta0.0000Rho2.04Eff Leverage0.0003Vega
Sangamo Therapeutics Stock Discussion
Sangamo Therapeutics recently presented critical pre-clinical data on its innovative next-generation integrase technology, the Modular Integrase (MINT) platform, highlighting a significant advancement in the field of genome editing. The announcement came as part of their participation at the 27th Amer...
No comment yet